This document provides guidelines for antimicrobial therapy for infective endocarditis, including recommended antibiotics, dosages, intervals, and durations for different types of valves and microorganisms. It lists treatment recommendations for streptococci and staphylococci infections, whether the valve is native or prosthetic, and whether the strain is methicillin-sensitive or methicillin-resistant. For infections resistant to gentamicin or other aminoglycosides, a fluoroquinolone may be used instead. The guidelines are adapted from the 2008 ACC/AHA Valvular Heart Disease Guidelines focused update.
This document provides guidelines for antimicrobial therapy for infective endocarditis, including recommended antibiotics, dosages, intervals, and durations for different types of valves and microorganisms. It lists treatment recommendations for streptococci and staphylococci infections, whether the valve is native or prosthetic, and whether the strain is methicillin-sensitive or methicillin-resistant. For infections resistant to gentamicin or other aminoglycosides, a fluoroquinolone may be used instead. The guidelines are adapted from the 2008 ACC/AHA Valvular Heart Disease Guidelines focused update.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOCX, PDF, TXT or read online from Scribd
This document provides guidelines for antimicrobial therapy for infective endocarditis, including recommended antibiotics, dosages, intervals, and durations for different types of valves and microorganisms. It lists treatment recommendations for streptococci and staphylococci infections, whether the valve is native or prosthetic, and whether the strain is methicillin-sensitive or methicillin-resistant. For infections resistant to gentamicin or other aminoglycosides, a fluoroquinolone may be used instead. The guidelines are adapted from the 2008 ACC/AHA Valvular Heart Disease Guidelines focused update.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOCX, PDF, TXT or read online from Scribd
Native valve Penicillin G 18-24 million U/24 4 weeks h IV in 6 equally divided doses Or Ceftriaxone 2g IV daily 4 weeks Plus Gentamicin 1 mg/kg IV 8 2 weeks hourly
Native valve - Vancomycin 30 mg/kg/24 h IV 4 weeks
lactam allergic in 2 equally divided doses, not to exceed 2g/24h unless serum levels are monitored Prosthetic valve Penicillin G 18-24 million U/24 6 weeks (vancomycin for h IV in 6 equally patients allergic to divided doses -lactams) Plus Gentamicin 1 mg/kg IV 8 2 weeks hourly STAPHYLOCOCCI
Valve Antibiotic Dosage & Interval Duration
Methicillin-sensitive Native valve Cloxacillin 2g IV 4 hourly 4-6 weeks Plus Gentamicin 1 mg/kg IV 8 2 weeks hourly Native valve - Vancomycin 30 mg/kg/24 h IV 4-6 weeks lactam allergic in 2 equally divided doses, not to exceed 2g/24h unless serum levels are monitored Prosthetic valve Cloxacillin 2g IV 4 hourly 6 weeks Plus Rifampicin 300mg PO 8 hourly 6 weeks Plus Gentamicin 1mg/kg IV 8 2 weeks hourly Methicillin-resistant (MRSA) Native valve Vancomycin 30 mg/kg/24 h IV 4-6 weeks in 2 equally divided doses, not to exceed 2g/24h unless serum levels are monitored Plus Gentamicin 1mg/kg IV 8 2 weeks hourly Prosthetic valve Vancomycin 30 mg/kg/24 h IV 6 weeks in 2 equally divided doses, not to exceed 2g/24h unless serum levels are monitored Plus Rifampicin 300mg PO 8 hourly 6 weeks Plus Gentamicin 1mg/kg IV 8 2 weeks hourly For strains resistant to gentamicin or other aminoglycosides, a fluoroquinolone may be used
Adapted form ACC/AHA Valvular Heart Disease Guidelines:2008 Focused Update